
Nuage
Unlocking the druggability of intrinsically disordered proteins to deliver a new wave of transformative cancer therapies.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredMar 30, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
- DHDenes Hnisz Founder and Observersource: nuagetx.com
- MBMateusz Biesaga Founder and Chief Technology Officersource: nuagetx.com
- XSXavier Salvatella Foundersource: nuagetx.com
Companies like Nuage
PPeptone$40M Series A · Jun 2022
HHotSpot Therapeutics$100M Series B+ · Nov 2021
AAtavistik Bio$40M Series B+ · Mar 2026
WWobble Genomics$1.66M Seed · Sep 2021
CCoultreon$125M Series A · Apr 2026GGenespire$52M Series B+ · Sep 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/nuage (get a free API key).